key: cord-0683210-v6yrr39c authors: Song, Andrew; Manukian, Gregor; Taylor, Amy; Anne, Pramila R.; Simone, Nicole L. title: Concerns for activated breathing control (ABC) with breast cancer in the era of COVID-19: Maximizing infection control while minimizing heart dose date: 2020-04-01 journal: Adv Radiat Oncol DOI: 10.1016/j.adro.2020.03.009 sha: 14de765ddbd4f070f1479f172d356b82727650f2 doc_id: 683210 cord_uid: v6yrr39c nan Active Breathing Control (ABC) devices employ moderate deep inspiration breath hold (DIBH) 1 techniques in order to spare cardiac structures from dosing in left breast cancer (LBC) patients and 2 is more commonly practiced than prone positioning 1 . ABC also helps in reducing dose to other 3 organs at risk, including lungs and liver 2 . However, in the era of the COVID-19 pandemic, there are 4 concerns regarding the safety of using such devices with risks of transmission amongst multiple 5 patients, especially since the virus has a relatively high transmission rate and increased risk for 6 fatality for elderly patients 3 . This issue is particularly poignant to cancer patients who may be 7 immunocompromised and are at increased risk of invasive ventilation, ICU admission, or death (39% 8 vs 8%) with COVID-19 4 . In addition, alternatives to ABC, such as prone positioning, may provide 9 comparable benefits to ABC without placing LBC patients in situations at risk for direct exposure 10 from shared respiratory devices. 11 At our institution, we utilize Active Breathing Coordinator™ (Elekta; Stockholm, Sweden) for our LBC 12 patients. We previously published the results from a prospective trial using this device in which we 13 demonstrated a median reduction in mean heart dose (MHD) of 1.7 Gy with a 8-year locoregional 14 relapse rate of 7 percent 5 . Additionally, a systematic review of ten studies showed similar results with 15 DIBH, including a reduction of MHD up to 3.4 Gy, translating to a 13.6 percent decrease in risk of 16 heart disease 6 . This includes reduction of dose to the left anterior descending artery, with mean dose 17 reduced by nearly half and coronary events at 10 years down to 2.55 percent from 4.03 percent 7 . 18 Respiratory droplets are one of the main methods of transmitting the SARS-CoV-2 virus 8 . These can 19 be generated through coughing, sneezing, mouth and nose breathing, and talking. The size and the 20 number of droplets can vary based on the expiratory activity, the region of origin in the respiratory 21 tract, and the type of pathogen 9 . SARS-CoV-2 particles have had reported diameters ranging from 22 0.06 to 0.14 microns 10 . SARS-CoV-2 viral particles in aerosols can remain viable for up to 3 hours 23 and up to 72 hours on plastic and stainless steel surfaces 11 . Aerosol models in healthy humans have 24 measured droplets from coughing as small as 0.1 microns, with the vast majority (97 percent) of 25 droplets as submicron in size 12 . Viral aerosols, such as those generated by influenza, tend to skew 26 towards this submicron size distribution 13 . 27 The Active Breathing Coordinator™ utilizes a mouthpiece and filter kit which are designed for single 28 patient use. The ViroMax® viral/bacterial filter is constructed of a Styrene-Acrylonitrile Copolymer 29 which supports the filter media constructed from a blend of modacrylic and polypropylene fibers. 30 This has been tested and certified to >99.99% viral and >99.999% bacterial efficiency (FDA GMP, 31 ISO 13485:2016, FDA 510(k) clearance K063526). The filter has been tested to 0.1 micron size 32 particles which should technically provide adequate protection from transmission. Since the SARS-33 CoV-2 virus may be as small as 0.06 microns, however, we have elected in our clinic to decide 34 whether or not to use ABC on a case-by-case basis due to these concerns. 35 As an extra precaution during this time of the pandemic, providers can consider alternatives to ABC. patients, however, including for those needing regional nodal irradiation, very medial or lateral 43 lumpectomy cavities, and for situations where anterior displacement of the heart towards the chest 44 wall may not lead to effective cardiac sparing 17 . Therefore, one can consider simulating patients in 45 both prone and supine positions and selecting a treatment plan that is most suitable for the patient. 46 1 field and IMRT 18 . 2 In summary, the COVID-19 pandemic gives radiation oncologists an opportunity to evaluate our 3 standard practices and create institutional guidelines taking into account: 1) the size of SARS-CoV-2 4 virus and 2) the type of device used for respiratory gating, in order to determine the risk-benefit ratio 5 acceptable for our patients during this time. Alternatives to ABC, including voluntary DIBH, prone 6 positioning, and optimizing treatment planning should also be considered to mitigate risk between 7 patients. 8 to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial Nationwide Trends in Heart-Sparing Techniques Utilized in Radiation 10 Therapy for Breast Cancer A seven-year experience of using moderate deep inspiration breath-hold 13 for patients with early-stage breast cancer and dosimetric comparison Understanding of COVID 19 based on current evidence Cancer patients in SARS-CoV-2 infection: a nationwide analysis in 19 Active Breathing Coordinator reduces radiation dose Influenza virus in human exhaled breath: An observational 2 study Radiation effect on late cardiopulmonary toxicity: An analysis 4 comparing supine DIBH versus prone techniques for breast treatment A prospective trial to compare deep inspiratory breath hold 6 (DIBH) with prone breast irradiation The UK HeartSpare Study: Randomised evaluation of voluntary 9 deep-inspiratory breath-hold in women undergoing breast radiotherapy Supine or Prone Breast Radiation: Upsides and Downsides Clinical implementation of intensity-modulated tangential beam 15 irradiation for breast cancer This work was supported in part by the NCI Cancer Center Grant P30CA056036.